Suppression of Coronary Atherosclerosis by Helix B Surface Peptide, a Nonerythropoietic, Tissue-Protective Compound Derived from Erythropoietin

Erythropoietin (EPO), a type I cytokine originally identified for its critical role in hematopoiesis, has been shown to have nonhematopoietic, tissue-protective effects, including suppression of atherosclerosis. However, prothrombotic effects of EPO hinder its potential clinical use in nonanemic pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ueba, Hiroto, Shiomi, Masashi, Brines, Michael, Yamin, Michael, Kobayashi, Tsutomu, Ako, Junya, Momomura, Shin-ichi, Cerami, Anthony, Kawakami, Masanobu
Format: Artigo
Idioma:Inglês
Publicat: ScholarOne 2013
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3745597/
https://ncbi.nlm.nih.gov/pubmed/23648638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2013.00037
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars